Publicado 4 números por año
ISSN Imprimir: 0893-9675
ISSN En Línea: 2162-6448
Indexed in
Hepatocellular Carcinoma: The Current Role of Surgical Intervention
SINOPSIS
As the incidence of hepatocellular carcinoma (HCC) continues to rise, so does our understanding of this disease and the number of available treatment options and strategies. Although surgical intervention often continues to play a central role, it must be placed in the proper context of what has rapidly become a multimodality, multidisciplinary disease. Understanding the nuances of managing HCC and its associations and treatment options are essential for making appropriate surgical decisions.
-
Li Zai-Bo, Chu Hong-Tao, Jia Min, Li Lin, Long noncoding RNA LINC01139 promotes the progression of hepatocellular carcinoma by upregulating MYBL2 via competitively binding to miR-30 family, Biochemical and Biophysical Research Communications, 525, 3, 2020. Crossref
-
Zhang Yanhe, Wang Hui, Li Chao, Gao Linlin, Zheng Yayun, Chang Wenjuan, Lu Chao, Zhao Xiaoguang, CircSMYD4 regulates proliferation, migration and apoptosis of hepatocellular carcinoma cells by sponging miR-584-5p, Cancer Cell International, 20, 1, 2020. Crossref
-
Wang Huancheng, Liu Jia, Exploration of Sorafenib Influences on Gene Expression of Hepatocellular Carcinoma, Frontiers in Genetics, 11, 2020. Crossref
-
Xu Jian, Shen Xiaomin, Zhang Bo, Su Rui, Cui Mingxuan, Yan Lihua, Cao Yu, Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma, Bioscience Reports, 41, 9, 2021. Crossref
-
Guo Xuan, Wang Ziying, Deng Xue, Lu Yantong, Huang Xuhui, Lin Juze, Lan Xiaohe, Su Qiao, Wang Changjun, Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184, Cell Cycle, 21, 15, 2022. Crossref